European Patent Office

T 1221/14 (Clostridial assays/ALLERGAN) of 09.05.2019

European Case Law Identifier
ECLI:EP:BA:2019:T122114.20190509
Date of decision
9 May 2019
Case number
T 1221/14
Online on
24 January 2020
Petition for review of
-
Application number
02807745.1
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS
Applicant name
ALLERGAN, INC.
Opponent name
Merz Pharma GmbH & Co. KGaA
IPSEN PHARMA S.A.S.
Board
3.3.01
Headnote
-
Relevant legal provisions
European Patent Convention Art 123(2)European Patent Convention Art 123(3)Rules of procedure of the Boards of Appeal Art 12(4)European Patent Convention Art 111(1)
Keywords
Late-filed requests, filed with statement of grounds of appeal
Late-filed request - admitted (yes)
Amendments - allowable (main request, first and second auxiliary requests
Amendments - no; third auxiliary request
Amendments - yes)
Appeal decision - remittal to the opposition division (yes)
Catchword
-
Cited cases
-
Citing cases
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the opposition division for further prosecution on the basis of the set of claims of the third auxiliary request filed with the statement of grounds of appeal dated 21 July 2014.